US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Alumis Inc.

9.90

+0.10001.02%

Post-market: 9.950.0500+0.51%19:12 EDT

Volume:4.73M

Turnover:47.02M

Market Cap:1.28B

PE:-2.60

High:10.55

Open:10.55

Low:9.65

Close:9.80

52wk High:31.35

52wk Low:3.76

Shares:129.00M

Float Shares:104.00M

Volume Ratio:0.81

T/O Rate:4.55%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.8005

EPS(LYR):-2.8616

ROE:-93.65%

ROA:-45.34%

PB:2.82

PE(LYR):-3.46

Loading ...

Overview Company News Filings

Small U.S. Stocks Decrease; Alumis Takes Biggest Hit

Alumis price target lowered to $27 from $35 at Baird

Top Midday Decliners

MT Newswires Live

Alumis price target lowered to $25 from $51 at Wells Fargo

Alumis falls -58.9%

U.S. Stocks on the MOVE-GoPro, TXNM Energy, Emergent BioSolutions

Alumis Down over 54%, on Pace for Record Percent Decrease

Alumis Set for Worst Day After Lupus Drug Misses Main Goal in Mid-Stage Trial

Alumis Eyes Late-Stage Lupus Study Despite Trial Miss

Alumis Reports Phase 2b Envudeucitinib Data in Lupus

Alumis' Lupus Drug Fails Mid-Stage Trial Goal

Alumis Says Phase 2b LUMUS Trial of Envudeucitinib in Systemic Lupus Erythematosus Misses Primary Endpoint

Alumis - Envudeucitinib Well Tolerated with no New Safety Signals in Lumus Trial

THOMSON REUTERS

Alumis - Lumus Phase 2B Trial of Envudeucitinib Did not Meet Primary and Secondary Endpoints

THOMSON REUTERS

Alumis - Robust Responses in Ifngs-High Subgroup Support Phase 3 Development of Envudeucitinib in Sle

THOMSON REUTERS

Alumis - on Track to Submit Nda for Envudeucitinib in Plaque Psoriasis in Q4 2026

THOMSON REUTERS

Alumis Announces Topline Results from Envudeucitinib Phase 2B Trial in Systemic Lupus Erythematosus (Sle)

THOMSON REUTERS

Alumis Inc. - Actively Evaluating Opportunities to Maximize Value of Our Oral Tyk2 Portfolio

THOMSON REUTERS

NASDAQ Trade Halt Halt News Pending at 07:25 Am

What Alumis (ALMS)'s Envudeucitinib Phase 3 Data and Deepening Losses Means For Shareholders

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/ALMS/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALMS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALMS\",,,,,undefined,":{"symbol":"ALMS","market":"US","secType":"STK","nameCN":"Alumis Inc.","latestPrice":9.9,"timestamp":1789070400000,"preClose":9.8,"halted":0,"volume":4731359,"hourTrading":{"tag":"盘后","latestPrice":9.95,"preClose":9.9,"latestTime":"19:12 EDT","volume":59351,"amount":587609.857739,"timestamp":1789081923775,"change":0.05,"changeRate":0.005051,"amplitude":0.017172},"delay":0,"changeRate":0.010204081632653024,"floatShares":104000000,"shares":129000000,"eps":-3.800544,"marketStatus":"Post-Mkt","change":0.1,"latestTime":"09-10 19:21:09 EDT","open":10.55,"high":10.55,"low":9.65,"amount":47022800.675859995,"amplitude":0.091837,"askPrice":10,"askSize":1,"bidPrice":9.86,"bidSize":4,"shortable":3,"etf":0,"ttmEps":-3.800544,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":4,"adr":0,"listingDate":1719547200000,"exchange":"NASDAQ","adjPreClose":9.8,"preHourTrading":{"tag":"盘前","latestPrice":10.58,"preClose":9.8,"latestTime":"09:29 EDT","volume":48221,"amount":501737.74493349995,"timestamp":1789046986722,"change":0.78,"changeRate":0.079592,"amplitude":0.043439},"postHourTrading":{"tag":"盘后","latestPrice":9.95,"preClose":9.9,"latestTime":"19:12 EDT","volume":59351,"amount":587609.857739,"timestamp":1789081923775,"change":0.05,"changeRate":0.005051,"amplitude":0.017172},"volumeRatio":0.805173,"impliedVol":0.8457,"impliedVolPercentile":0.2231},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALMS\",,,,,undefined,":{"symbol":"ALMS","floatShares":104000000,"roa":"-45.34%","roe":"-93.65%","lyrEps":-2.861649,"volumeRatio":0.805173,"shares":129000000,"dividePrice":0,"high":10.55,"amplitude":0.091837,"preClose":9.8,"low":9.65,"week52Low":3.76,"pbRate":"2.82","psRate":"172.63","week52High":31.35,"institutionHeld":0,"latestPrice":9.9,"committee":0.6,"eps":-3.800544,"divideRate":0,"volume":4731359,"delay":0,"ttmEps":-3.800544,"open":10.55,"prevYearClose":9.76,"prevWeekClose":11.1,"prevMonthClose":21.81,"prevQuarterClose":28.14,"fiveDayClose":10.35,"twentyDayClose":25.55,"sixtyDayClose":23},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALMS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"ALMS","fiscalQuarterEnding":"2026/06","expectedEps":-0.7,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-0.78},{"market":"US","date":"2026-05-14","symbol":"ALMS","fiscalQuarterEnding":"2026/03","expectedEps":-0.79,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"post","actualEps":-0.74},{"market":"US","date":"2026-03-19","symbol":"ALMS","fiscalQuarterEnding":"2025/12","expectedEps":-0.97,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773892800000,"reportTimeType":"post","actualEps":-0.95},{"market":"US","date":"2025-11-13","symbol":"ALMS","fiscalQuarterEnding":"2025/09","expectedEps":-0.92,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-1.06},{"market":"US","date":"2025-08-13","symbol":"ALMS","fiscalQuarterEnding":"2025/06","expectedEps":-1.11,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-1.17}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALMS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALMS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.4,"hold":0.1,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4,"analysts":10,"updateTime":1788408000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALMS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALMS","date":"2026-09-09","current":-2.60489,"percent":0.504537,"low":-16.271116,"twenty":-12.268318,"median":-3.137731,"eighty":-1.170751,"high":-0.443678,"avg":-5.273621,"sd":5.017137,"marketCap":1369424828},"quantilePoints":[{"date":"2024-06-28","current":-4.084559,"twenty":-4.913756,"median":-4.913756,"eighty":-4.416238,"marketCap":689534895},{"date":"2024-07-05","current":-3.516406,"twenty":-4.747917,"median":-3.851156,"eighty":-3.59564,"marketCap":593622147},{"date":"2024-07-12","current":-3.405847,"twenty":-4.063676,"median":-3.825051,"eighty":-3.58397,"marketCap":574958044},{"date":"2024-07-19","current":-4.023985,"twenty":-4.026561,"median":-3.851156,"eighty":-3.52869,"marketCap":679309112},{"date":"2024-07-26","current":-4.023985,"twenty":-4.117224,"median":-3.947896,"eighty":-3.58397,"marketCap":679309112},{"date":"2024-08-02","current":-4.178507,"twenty":-4.123137,"median":-3.980142,"eighty":-3.620209,"marketCap":705394582},{"date":"2024-08-09","current":-3.850149,"twenty":-4.108328,"median":-3.938677,"eighty":-3.693301,"marketCap":649962958},{"date":"2024-08-16","current":-3.683794,"twenty":-4.085032,"median":-3.914533,"eighty":-3.659692,"marketCap":696362265},{"date":"2024-08-23","current":-3.672282,"twenty":-4.078883,"median":-3.855481,"eighty":-3.667968,"marketCap":694186133},{"date":"2024-08-30","current":-3.655014,"twenty":-4.050383,"median":-3.84693,"eighty":-3.659692,"marketCap":690921935},{"date":"2024-09-06","current":-3.442045,"twenty":-4.027205,"median":-3.798947,"eighty":-3.608967,"marketCap":650663491},{"date":"2024-09-13","current":-3.33556,"twenty":-4.023985,"median":-3.741353,"eighty":-3.511116,"marketCap":630534270},{"date":"2024-09-20","current":-3.301025,"twenty":-4.023985,"median":-3.709695,"eighty":-3.405847,"marketCap":624005873},{"date":"2024-09-27","current":-3.211808,"twenty":-3.980142,"median":-3.685233,"eighty":-3.395997,"marketCap":607140850},{"date":"2024-10-04","current":-2.803137,"twenty":-3.959602,"median":-3.672282,"eighty":-3.303903,"marketCap":529888161},{"date":"2024-10-11","current":-2.978693,"twenty":-3.946725,"median":-3.656453,"eighty":-3.263611,"marketCap":563074175},{"date":"2024-10-18","current":-3.462191,"twenty":-3.930629,"median":-3.608967,"eighty":-3.220442,"marketCap":654471723},{"date":"2024-10-25","current":-3.424777,"twenty":-3.915649,"median":-3.608753,"eighty":-3.22332,"marketCap":647399293},{"date":"2024-11-01","current":-3.254977,"twenty":-3.914533,"median":-3.516406,"eighty":-3.231953,"marketCap":615301345},{"date":"2024-11-08","current":-3.459313,"twenty":-3.86344,"median":-3.50536,"eighty":-3.240587,"marketCap":653927690},{"date":"2024-11-15","current":-2.016571,"twenty":-3.859807,"median":-3.465068,"eighty":-3.22332,"marketCap":481504843},{"date":"2024-11-22","current":-2.155567,"twenty":-3.851156,"median":-3.454996,"eighty":-3.18015,"marketCap":514693313},{"date":"2024-11-29","current":-2.109995,"twenty":-3.85035,"median":-3.444923,"eighty":-3.067334,"marketCap":503811848},{"date":"2024-12-06","current":-2.050751,"twenty":-3.847574,"median":-3.439167,"eighty":-2.978693,"marketCap":489665943},{"date":"2024-12-13","current":-1.911755,"twenty":-3.823752,"median":-3.419021,"eighty":-2.94646,"marketCap":456477473},{"date":"2024-12-20","current":-2.009736,"twenty":-3.802749,"median":-3.405847,"eighty":-2.329653,"marketCap":479872624},{"date":"2024-12-27","current":-1.836561,"twenty":-3.764391,"median":-3.395997,"eighty":-2.153744,"marketCap":438523055},{"date":"2025-01-03","current":-1.925427,"twenty":-3.741353,"median":-3.367218,"eighty":-2.142807,"marketCap":459741913},{"date":"2025-01-10","current":-1.595028,"twenty":-3.741353,"median":-3.312536,"eighty":-2.023407,"marketCap":380851289},{"date":"2025-01-17","current":-1.745417,"twenty":-3.740777,"median":-3.298147,"eighty":-1.989684,"marketCap":416760124},{"date":"2025-01-24","current":-1.522113,"twenty":-3.738475,"median":-3.27944,"eighty":-1.964163,"marketCap":363440944},{"date":"2025-01-31","current":-1.704402,"twenty":-3.735597,"median":-3.263611,"eighty":-1.93682,"marketCap":406966805},{"date":"2025-02-07","current":-1.291973,"twenty":-3.709695,"median":-3.247782,"eighty":-1.911755,"marketCap":308489544},{"date":"2025-02-14","current":-1.187157,"twenty":-3.703939,"median":-3.22332,"eighty":-1.873019,"marketCap":283462173},{"date":"2025-02-21","current":-1.178042,"twenty":-3.690125,"median":-3.211808,"eighty":-1.829725,"marketCap":281285880},{"date":"2025-02-28","current":-1.059555,"twenty":-3.68437,"median":-3.162882,"eighty":-1.759544,"marketCap":252994070},{"date":"2025-03-07","current":-1.111963,"twenty":-3.676887,"median":-3.070787,"eighty":-1.711693,"marketCap":265507755},{"date":"2025-03-14","current":-1.041326,"twenty":-3.672858,"median":-3.006033,"eighty":-1.678881,"marketCap":248641484},{"date":"2025-03-21","current":-0.693421,"twenty":-3.667968,"median":-2.978693,"eighty":-1.565406,"marketCap":204027476},{"date":"2025-03-28","current":-1.042906,"twenty":-3.659692,"median":-2.965742,"eighty":-1.505251,"marketCap":306857324},{"date":"2025-04-04","current":-1.85837,"twenty":-3.65559,"median":-2.803137,"eighty":-1.500694,"marketCap":546793636},{"date":"2025-04-11","current":-1.198232,"twenty":-3.63199,"median":-2.286587,"eighty":-1.463027,"marketCap":352559478},{"date":"2025-04-17","current":-0.924562,"twenty":-3.622781,"median":-2.176074,"eighty":-1.280365,"marketCap":272036635},{"date":"2025-04-25","current":-0.791425,"twenty":-3.613572,"median":-2.146452,"eighty":-1.183511,"marketCap":232863359},{"date":"2025-05-02","current":-0.848748,"twenty":-3.60871,"median":-2.125945,"eighty":-1.162092,"marketCap":249729630},{"date":"2025-05-09","current":-0.930109,"twenty":-3.590112,"median":-2.016571,"eighty":-1.140673,"marketCap":273668854},{"date":"2025-05-16","current":-0.890525,"twenty":-3.561975,"median":-1.997203,"eighty":-1.105127,"marketCap":305759157},{"date":"2025-05-23","current":-0.766929,"twenty":-3.530406,"median":-1.968721,"eighty":-1.070948,"marketCap":263322832},{"date":"2025-05-30","current":-0.619565,"twenty":-3.51429,"median":-1.964163,"eighty":-1.045883,"marketCap":212725677},{"date":"2025-06-06","current":-0.530829,"twenty":-3.506511,"median":-1.95277,"eighty":-1.037224,"marketCap":182258572},{"date":"2025-06-13","current":-0.503891,"twenty":-3.48667,"median":-1.925427,"eighty":-0.984896,"marketCap":173009629},{"date":"2025-06-20","current":-0.476954,"twenty":-3.466829,"median":-1.916313,"eighty":-0.943233,"marketCap":163760687},{"date":"2025-06-27","current":-0.522906,"twenty":-3.464493,"median":-1.909477,"eighty":-0.920124,"marketCap":179538295},{"date":"2025-07-03","current":-0.538752,"twenty":-3.462191,"median":-1.878715,"eighty":-0.88573,"marketCap":184978849},{"date":"2025-07-11","current":-0.564105,"twenty":-3.459313,"median":-1.85837,"eighty":-0.848748,"marketCap":193683736},{"date":"2025-07-18","current":-0.556182,"twenty":-3.450679,"median":-1.833144,"eighty":-0.808067,"marketCap":190963459},{"date":"2025-07-25","current":-0.611642,"twenty":-3.444923,"median":-1.819538,"eighty":-0.791425,"marketCap":210005399},{"date":"2025-08-01","current":-0.65601,"twenty":-3.444923,"median":-1.768203,"eighty":-0.766929,"marketCap":225238952},{"date":"2025-08-08","current":-1.301335,"twenty":-3.442045,"median":-1.745417,"eighty":-0.761839,"marketCap":446809517},{"date":"2025-08-15","current":-2.007939,"twenty":-3.439167,"median":-1.743138,"eighty":-0.765537,"marketCap":456842285},{"date":"2025-08-22","current":-2.103991,"twenty":-3.427655,"median":-1.761367,"eighty":-0.766929,"marketCap":478695789},{"date":"2025-08-29","current":-2.14973,"twenty":-3.424777,"median":-1.805264,"eighty":-0.766929,"marketCap":489102219},{"date":"2025-09-05","current":-2.103991,"twenty":-3.415567,"median":-1.826307,"eighty":-0.771366,"marketCap":478695789},{"date":"2025-09-12","current":-1.994217,"twenty":-3.40866,"median":-1.836561,"eighty":-0.773109,"marketCap":453720356},{"date":"2025-09-19","current":-1.9622,"twenty":-3.406179,"median":-1.867544,"eighty":-0.787793,"marketCap":446435855},{"date":"2025-09-26","current":-1.824983,"twenty":-3.405847,"median":-1.875296,"eighty":-0.795863,"marketCap":415216564},{"date":"2025-10-03","current":-1.811262,"twenty":-3.397967,"median":-1.860219,"eighty":-0.799931,"marketCap":412094635},{"date":"2025-10-10","current":-2.071974,"twenty":-3.391392,"median":-1.873019,"eighty":-0.803629,"marketCap":471411288},{"date":"2025-10-17","current":-2.108565,"twenty":-3.371823,"median":-1.884428,"eighty":-0.807327,"marketCap":479736432},{"date":"2025-10-24","current":-2.108565,"twenty":-3.341892,"median":-1.893592,"eighty":-0.812505,"marketCap":479736432},{"date":"2025-10-31","current":-2.131434,"twenty":-3.317141,"median":-1.904969,"eighty":-0.82249,"marketCap":484939647},{"date":"2025-11-07","current":-2.158878,"twenty":-3.30563,"median":-1.911755,"eighty":-0.843135,"marketCap":491183505},{"date":"2025-11-14","current":-2.422653,"twenty":-3.301601,"median":-1.918592,"eighty":-0.848547,"marketCap":551197167},{"date":"2025-11-21","current":-2.946741,"twenty":-3.29642,"median":-1.93682,"eighty":-0.86502,"marketCap":722402348},{"date":"2025-11-28","current":-3.266113,"twenty":-3.290089,"median":-1.953052,"eighty":-0.869088,"marketCap":800697401},{"date":"2025-12-05","current":-3.534386,"twenty":-3.297571,"median":-1.962042,"eighty":-0.870197,"marketCap":866465244},{"date":"2025-12-12","current":-4.943882,"twenty":-3.336738,"median":-1.966442,"eighty":-0.879813,"marketCap":1212007408},{"date":"2025-12-19","current":-4.709675,"twenty":-3.399937,"median":-1.972322,"eighty":-0.888607,"marketCap":1154591037},{"date":"2025-12-26","current":-4.854457,"twenty":-3.410963,"median":-1.990368,"eighty":-0.898223,"marketCap":1190084794},{"date":"2026-01-02","current":-4.156097,"twenty":-3.436865,"median":-1.996504,"eighty":-0.911618,"marketCap":1018879613},{"date":"2026-01-09","current":-7.741582,"twenty":-3.449528,"median":-2.003365,"eighty":-0.920124,"marketCap":1897872066},{"date":"2026-01-16","current":-12.290084,"twenty":-3.466829,"median":-2.013154,"eighty":-0.925671,"marketCap":3012950964},{"date":"2026-01-23","current":-13.362987,"twenty":-3.516406,"median":-2.019374,"eighty":-0.930109,"marketCap":3275976472},{"date":"2026-01-30","current":-13.647739,"twenty":-3.577828,"median":-2.030809,"eighty":-0.937506,"marketCap":3345784190},{"date":"2026-02-06","current":-13.393497,"twenty":-3.626234,"median":-2.053678,"eighty":-0.942816,"marketCap":3283455871},{"date":"2026-02-13","current":-13.6274,"twenty":-3.672282,"median":-2.062826,"eighty":-0.944902,"marketCap":3340797925},{"date":"2026-02-20","current":-14.850306,"twenty":-3.690125,"median":-2.071974,"eighty":-0.965612,"marketCap":3640597141},{"date":"2026-02-27","current":-15.244382,"twenty":-3.739051,"median":-2.087982,"eighty":-0.981145,"marketCap":3737206037},{"date":"2026-03-06","current":-14.054527,"twenty":-3.801818,"median":-2.103991,"eighty":-0.986058,"marketCap":3445509501},{"date":"2026-03-13","current":-12.727381,"twenty":-3.85035,"median":-2.108565,"eighty":-0.99467,"marketCap":3120155674},{"date":"2026-03-20","current":-13.002303,"twenty":-3.914756,"median":-2.117713,"eighty":-1.01599,"marketCap":3163785497},{"date":"2026-03-27","current":-13.758909,"twenty":-3.96371,"median":-2.12686,"eighty":-1.031756,"marketCap":3347886444},{"date":"2026-04-02","current":-11.882219,"twenty":-4.025273,"median":-2.141239,"eighty":-1.038592,"marketCap":2891240839},{"date":"2026-04-10","current":-11.991997,"twenty":-4.096739,"median":-2.146452,"eighty":-1.041326,"marketCap":2917952699},{"date":"2026-04-17","current":-13.068872,"twenty":-4.165061,"median":-2.15037,"eighty":-1.042274,"marketCap":3179983325},{"date":"2026-04-24","current":-13.5864,"twenty":-4.472062,"median":-2.155567,"eighty":-1.044692,"marketCap":3305910664},{"date":"2026-05-01","current":-12.906818,"twenty":-4.742038,"median":-2.161164,"eighty":-1.045883,"marketCap":3140551531},{"date":"2026-05-08","current":-12.420656,"twenty":-4.831463,"median":-2.172599,"eighty":-1.054086,"marketCap":3022256152},{"date":"2026-05-15","current":-13.226323,"twenty":-4.877452,"median":-2.191451,"eighty":-1.062289,"marketCap":3140127467},{"date":"2026-05-22","current":-11.905302,"twenty":-5.029048,"median":-2.200043,"eighty":-1.070948,"marketCap":2826497196},{"date":"2026-05-29","current":-11.491811,"twenty":-7.697296,"median":-2.214811,"eighty":-1.081885,"marketCap":2728328372},{"date":"2026-06-05","current":-10.949441,"twenty":-10.746475,"median":-2.229773,"eighty":-1.094189,"marketCap":2599561472},{"date":"2026-06-12","current":-11.223311,"twenty":-10.767935,"median":-2.309816,"eighty":-1.101025,"marketCap":2664582382},{"date":"2026-06-18","current":-12.377862,"twenty":-10.942997,"median":-2.358363,"eighty":-1.105127,"marketCap":2938690139},{"date":"2026-06-26","current":-13.441123,"twenty":-11.434889,"median":-2.409687,"eighty":-1.106494,"marketCap":3191124259},{"date":"2026-07-02","current":-14.305694,"twenty":-11.51629,"median":-2.443671,"eighty":-1.111963,"marketCap":3396386347},{"date":"2026-07-10","current":-16.271116,"twenty":-11.77244,"median":-2.7977,"eighty":-1.135362,"marketCap":3863006994},{"date":"2026-07-17","current":-14.622524,"twenty":-11.882219,"median":-2.91667,"eighty":-1.139306,"marketCap":3471606615},{"date":"2026-07-24","current":-15.197115,"twenty":-11.985852,"median":-2.970059,"eighty":-1.141585,"marketCap":3608023034},{"date":"2026-07-31","current":-15.546165,"twenty":-12.051591,"median":-2.978693,"eighty":-1.145231,"marketCap":3690892821},{"date":"2026-08-07","current":-14.928615,"twenty":-12.229666,"median":-3.006033,"eighty":-1.151611,"marketCap":3544277044},{"date":"2026-08-14","current":-13.30798,"twenty":-12.354486,"median":-3.070787,"eighty":-1.160269,"marketCap":3159514183},{"date":"2026-08-21","current":-6.740728,"twenty":-12.30227,"median":-3.108556,"eighty":-1.162092,"marketCap":2958889563},{"date":"2026-08-28","current":-6.843932,"twenty":-12.28999,"median":-3.129848,"eighty":-1.162092,"marketCap":3004191897},{"date":"2026-09-04","current":-3.349723,"twenty":-12.282955,"median":-3.137731,"eighty":-1.167561,"marketCap":1470384315},{"date":"2026-09-09","current":-3.119724,"twenty":-12.268318,"median":-3.137731,"eighty":-1.170751,"marketCap":1369424828}],"updateTime":1789082469513},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALMS\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664869315","title":"Small U.S. Stocks Decrease; Alumis Takes Biggest Hit","url":"https://stock-news.laohu8.com/highlight/detail?id=2664869315","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664869315?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:20","pubTimestamp":1788294000,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of small-cap companies dropped Tuesday, as the Russell 2000 Index declined 1.2%, and the S&P Small Cap 600 Index was down 1.2%.Among companies with a market value of $1 billion to $6.7 billion, Alumis Inc. was the biggest laggard during the session, dropping 57%, followed by shares of Advasa Holdings Inc., which dropped 19%. Shares of Rezolve AI PLC dropped 17%, Enovis Corp. shares tumbled 17%, and Falcon's Beyond Global Inc. tumbled 16%.Fervo Energy Co. was the best performer, surging 28%, followed by Comstock Resources Inc., which surged 11%. MiniMed Group Inc. shares surged 11%, Mega Fortune Co. Ltd. jumped 10%, and shares of Novavax Inc. surged 8.0%.Major stock indexes in the U.S. dropped Tuesday as the Nasdaq Composite Index dropped 1.0%. Meanwhile, the S&P 500 Index fell 0.7%, and the Dow Jones Industrial Average dropped 0.8%.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664786659","title":"Alumis price target lowered to $27 from $35 at Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2664786659","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664786659?lang=en_us&edition=fundamental","pubTime":"2026-09-02 03:25","pubTimestamp":1788290709,"startTime":"0","endTime":"0","summary":"Baird lowered the firm’s price target on Alumis (ALMS) to $27 from $35 and keeps an Outperform rating on the shares. Published first on TheFly – th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alumis-price-target-lowered-to-27-from-35-at-baird-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alumis-price-target-lowered-to-27-from-35-at-baird-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664371865","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2664371865","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664371865?lang=en_us&edition=fundamental","pubTime":"2026-09-02 02:21","pubTimestamp":1788286893,"startTime":"0","endTime":"0","summary":"Alumis  said Tuesday that a phase 2 study of its envudeucitinib experimental drug in moderate-to-severe systemic lupus erythematosus failed to meet its primary and secondary endpoints in the overall trial population.Shares slumped nearly 59% as intraday trading volume catapulted to over 20.9 million from a daily average of about 1.3 million.Enovis  has signed a binding offer to acquire eCential Robotics for 176 million euros  in cash, plus up to 35 million euros in milestone payments, the company said Tuesday.BMO Capital adjusted the Enovis price target to $27 from $30, while maintaining its outperform rating.Shares dropped 10% as intraday trading volume climbed to over 1.9 million from a daily average of about 1.1 million.Cango  reported a Q2 loss from continuing operations late Monday while revenue more than halved.Shares slumped 22%, with intraday trading volume at over 419,000, versus a daily average of about 259,000.Price: 9.00, Change: -12.81, Percent Change: -58.73","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2065732104.USD","ENOV","BK4023","ALMS","IE0034390439.USD","BK4600","BK4122","IE00B19Z6F94.USD","BK4082","BK4007","BK4214","CANG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664486591","title":"Alumis price target lowered to $25 from $51 at Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2664486591","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664486591?lang=en_us&edition=fundamental","pubTime":"2026-09-02 02:20","pubTimestamp":1788286815,"startTime":"0","endTime":"0","summary":"Wells Fargo lowered the firm’s price target on Alumis (ALMS) to $25 from $51 and keeps an Overweight rating on the shares after the company’s Phase...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alumis-price-target-lowered-to-25-from-51-at-wells-fargo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alumis-price-target-lowered-to-25-from-51-at-wells-fargo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMS","PGF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664786864","title":"Alumis falls -58.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664786864","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664786864?lang=en_us&edition=fundamental","pubTime":"2026-09-02 00:05","pubTimestamp":1788278728,"startTime":"0","endTime":"0","summary":"Alumis (ALMS) is down -58.9%, or -$12.85 to $8.96. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alumis-falls-58-9-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alumis-falls-58-9-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664296850","title":"U.S. Stocks on the MOVE-GoPro, TXNM Energy, Emergent BioSolutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2664296850","media":"Reuters","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664296850?lang=en_us&edition=fundamental","pubTime":"2026-09-01 23:48","pubTimestamp":1788277712,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-GoPro, TXNM Energy, Emergent BioSolutionsSeptember 1 (Reuters)-The main U.S. stock indexes slipped on Tuesday, as elevated bond yields and higher oil prices kept investors","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL6N44T0X0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AXON","CANG","MYGN","PK","AEHL","CDNS","BMY","FINV","RDAC","XHR","IHE","CIBR","ABNG","BKNG","HUT","OXB.UK","HOOG","SSM","BBIO","RDACU","ABNB","EBS","LHSW","CLOD","EXPE","MRNA","CAPR","ELAB","GPRO","IAI","PMVP","CRWD","DLTR","CRK","IBKR","SRE","GROV","GOTU","HWM","TXNM","HOOD","JELD","RSPS","LPLA","MRNY","MDT","ALMS","SST","PSWD","FRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664485218","title":"Alumis Down over 54%, on Pace for Record Percent Decrease","url":"https://stock-news.laohu8.com/highlight/detail?id=2664485218","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664485218?lang=en_us&edition=fundamental","pubTime":"2026-09-01 22:14","pubTimestamp":1788272040,"startTime":"0","endTime":"0","summary":"Alumis Inc.  is currently at $9.98, down $11.83 or 54.24%--Would be lowest close since Jan. 5, 2026, when it closed at $8.31--Would be largest percent decrease on record --Currently down six of the past seven days--Currently down five consecutive days; down 58.35% over this period--Longest losing streak since July 29, 2026, when it fell for six straight trading days--Worst five day stretch on record --Up 2.25% year-to-date--Down 67.06% from its all-time closing high of $30.30 on July 9, 2026--Up 112.34% from 52 weeks ago , when it closed at $4.70--Down 67.06% from its 52-week closing high of $30.30 on July 9, 2026--Up 152.66% from its 52-week closing low of $3.95 on Sept. 29, 2025--Traded as low as $9.55; lowest intraday level since Jan. 5, 2026, when it hit $7.85--Down 56.21% at today's intraday low; largest intraday percent decrease on record All data as of 10:10:43 AM ETSource: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664085446","title":"Alumis Set for Worst Day After Lupus Drug Misses Main Goal in Mid-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2664085446","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664085446?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:44","pubTimestamp":1788270288,"startTime":"0","endTime":"0","summary":"BUZZ-Alumis set for worst day after lupus drug misses main goal in mid-stage trialUpdates** Shares of biopharma company AlumisALMS.Ofall54.2% to $9.99, their lowest since January** Stock on track for ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4N44T19V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664851727","title":"Alumis Eyes Late-Stage Lupus Study Despite Trial Miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2664851727","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664851727?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:12","pubTimestamp":1788268328,"startTime":"0","endTime":"0","summary":"UPDATE 1-Alumis eyes late-stage lupus study despite trial missSept 1 (Reuters)-AlumisALMS.Osaid on Tuesday it plans to advance its experimental drug for a type of immunity-related condition in a small","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4N44T11D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664585165","title":"Alumis Reports Phase 2b Envudeucitinib Data in Lupus","url":"https://stock-news.laohu8.com/highlight/detail?id=2664585165","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664585165?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:58","pubTimestamp":1788267531,"startTime":"0","endTime":"0","summary":"Alumis Inc. ( ($ALMS) ) has issued an announcement. On September 1, 2026, Alumis reported topline data from its Phase 2b LUMUS trial of envudeuciti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alumis-reports-phase-2b-envudeucitinib-data-in-lupus?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alumis-reports-phase-2b-envudeucitinib-data-in-lupus?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664554428","title":"Alumis' Lupus Drug Fails Mid-Stage Trial Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2664554428","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664554428?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:34","pubTimestamp":1788262464,"startTime":"0","endTime":"0","summary":"Alumis' lupus drug fails mid-stage trial goalSept 1 (Reuters)-AlumisALMS.Osaid on Tuesday its experimental drug failed to meet the main goal of a mid-stage trial in patients with a chronic autoimmune diseasecalled systemic lupus erythematosus.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4N44T119:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664385546","title":"Alumis Says Phase 2b LUMUS Trial of Envudeucitinib in Systemic Lupus Erythematosus Misses Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2664385546","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664385546?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:31","pubTimestamp":1788262270,"startTime":"0","endTime":"0","summary":"Alumis says Phase 2b LUMUS trial of envudeucitinib in systemic lupus erythematosus misses primary endpointAlumis reported topline results from its Phase 2b LUMUS trial of envudeucitinib in moderate-to","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL31FSq0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","SG9999014021.USD","LU2210149790.SGD","NDAQ","IE00BGHQF748.EUR","IE00BQXX3D17.EUR","BCDF","IE00BKPKM429.USD","IE00BQXX3F31.USD","BK4007","IE00B3QW5Z07.USD","SG9999014005.SGD","IE00BQXX3C00.GBP","SG9999014039.USD","BK4112","IE00B64PRP62.GBP","LU2095319765.USD","IE00BN0W2W23.USD","BK4585","IE00BN0W2T93.GBP","BK4588","LU0314104364.USD","SG9999014013.SGD","IE00BN0W2V16.EUR","ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664855169","title":"Alumis - Envudeucitinib Well Tolerated with no New Safety Signals in Lumus Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2664855169","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664855169?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:30","pubTimestamp":1788262203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44T0JZ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALMS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664855166","title":"Alumis - Lumus Phase 2B Trial of Envudeucitinib Did not Meet Primary and Secondary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2664855166","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664855166?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:30","pubTimestamp":1788262203,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44T0JZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664855135","title":"Alumis - Robust Responses in Ifngs-High Subgroup Support Phase 3 Development of Envudeucitinib in Sle","url":"https://stock-news.laohu8.com/highlight/detail?id=2664855135","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664855135?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:30","pubTimestamp":1788262203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44T0JZ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664551548","title":"Alumis - on Track to Submit Nda for Envudeucitinib in Plaque Psoriasis in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2664551548","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664551548?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:30","pubTimestamp":1788262203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44T0JZ:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664163855","title":"Alumis Announces Topline Results from Envudeucitinib Phase 2B Trial in Systemic Lupus Erythematosus (Sle)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664163855","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664163855?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:30","pubTimestamp":1788262203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44T0JZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALMS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664102855","title":"Alumis Inc. - Actively Evaluating Opportunities to Maximize Value of Our Oral Tyk2 Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2664102855","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664102855?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:30","pubTimestamp":1788262203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44T0JZ:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664855646","title":"NASDAQ Trade Halt Halt News Pending at 07:25 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2664855646","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664855646?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:25","pubTimestamp":1788261900,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTHALT NEWS PENDING AT 07:25 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nAQN2MHHSA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660041619","title":"What Alumis (ALMS)'s Envudeucitinib Phase 3 Data and Deepening Losses Means For Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2660041619","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660041619?lang=en_us&edition=fundamental","pubTime":"2026-08-19 09:22","pubTimestamp":1787102572,"startTime":"0","endTime":"0","summary":"Earlier in August 2026, Alumis Inc. reported second-quarter results showing revenue of US$1.66 million and a net loss of US$142.22 million, reversing a net profit a year earlier as loss per share widened sharply.\nA few days before that earnings release, Alumis reported positive topline Phase 3 ONWARD3 extension data for its oral TYK2 inhibitor envudeucitinib in plaque psoriasis and outlined plans to file a U.S. FDA New Drug Application this year, highlighting a potential first-in-class,...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alms/alumis/news/what-alumis-almss-envudeucitinib-phase-3-data-and-deepening","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alms/alumis/news/what-alumis-almss-envudeucitinib-phase-3-data-and-deepening","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ALMS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":2,"totalSize":128,"code":"91000000","status":"200"}]}}